Minnesota 2025-2026 Regular Session

Minnesota House Bill HF1844

Introduced
3/3/25  

Caption

Approval of an added flavor to inhaled cannabis products prohibited.

Impact

If enacted, HF1844 would significantly alter the landscape of cannabis product regulation in Minnesota. The bill is positioned as a consumer safety measure aimed at reducing the risk of products designed to attract children or other vulnerable populations. By restricting additives and flavors that can mimic popular confections or beverages, the legislation aims to ensure that cannabis products are not inadvertently marketed towards minors or those less aware of their contents. This move could also align Minnesota's regulations more closely with evolving standards seen in other states, which have already taken steps to regulate flavored inhaled products more strictly.

Summary

House File 1844 (HF1844) proposes amendments to existing Minnesota laws regarding the sale and approval of cannabis products, specifically aimed at banning flavored inhaled cannabis products. The bill is authored by representatives Perryman and Scott and was introduced for consideration in the Ninety-Fourth Legislative Session. It seeks to establish a clear definition of product categories for cannabis and hemp-derived products while instituting prohibitions on added flavors that could appeal to younger consumers or mimic common food items. The legislation empowers the governing office to set THC limits for these products and prohibits certain presentations that may mislead consumers regarding flavors.

Contention

Debate surrounding HF1844 may center on the implications for cannabis product manufacturers and retailers. Proponents argue that banning flavors is essential for consumer protection and youth prevention, suggesting that such measures will promote responsible consumption amidst growing health concerns regarding flavored tobacco and cannabis products. Conversely, opponents may express concerns over the potential economic impact on local businesses and the broader implications for the cannabis industry in Minnesota. Questions about market fairness and competition could arise, especially if neighboring states adopt less restrictive measures. Moreover, there may be calls for clarity on what constitutes permissible product presentations to avoid confusion for producers and consumers alike.

Companion Bills

MN SF1820

Similar To Inhaled cannabis product added flavor approval prohibition provision

Previously Filed As

MN SF1820

Inhaled cannabis product added flavor approval prohibition provision

MN HF755

Office of Cannabis Management required to establish limits on the total THC in cannabis flower and cannabis products; addition of ingredients to impart a taste or smell to cannabis products intended to be consumed through the inhalation of smoke, vapor, or aerosol prohibited; warnings about cannabis consumption required to include a warning regarding cancer; and advertisements prohibited that promote the co-consumption of alcohol and cannabis.

MN SF4434

THC potency limits establishment for various cannabis products

MN SF3591

Cannabis concentrate, cannabis flower, topical, or transdermal hemp products THC potency limits establishment and retail location and product labeling requirements provisions

MN SF556

Cannabis selling and advertising provisions modifications

MN SF2174

Office of Cannabis Management enforcement of THC content and potency limitations requirement provision

MN HF1254

Manufacture of certain products for sale outside of Minnesota provided, tetrahydrocannabivarin designated as a nonintoxicating cannabinoid, potency limits modified, social equity ownership requirements lowered to 51 percent, manufacturing limits established, and cannabis cultivator license authorizations clarified.

MN HF4201

Cannabis business and hemp business license provisions modified, and cannabinoid product and lower-potency hemp edible labeling requirements modified.

MN SF2172

Various cannabis provisions modifications

MN SF2165

Medical cannabis combination business plant canopy increase to cultivate cannabis sold as medical cannabis flower or medical cannabinoid products provision

Similar Bills

No similar bills found.